What is the usage of Imatinib Mesylate ?
Created 1 month ago by marykudro

Imatinib Mesylate is a medicine used by healthcare professionals for the following: Patients are suffering from Philadelphia chromosome-positive chronic myeloid leukemia, patients with myelodysplastic/ myeloproliferative diseases, patients with aggressive systemic mastocytosis, patients with hypereosinophilic syndrome and chronic eosinophilic leukemia who have the FIP1L1-PDGFRα fusion kinase, patients with unresectable, recurrent, and metastatic dermatofibrosarcoma protuberans, patients with Kit (CD117) positive unresectable and metastatic malignant gastrointestinal stromal tumors, etc. The general dosage of Imatinib Mesylate is the administration of 400 mg or 600 mg once daily, or a dose of 800 mg should be administered as 400 mg twice a day.